CRYOPORT, INC. Operating Lease Cost
CRYOPORT, INC. (CYRX) reported Operating Lease Cost of $3.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-06
- CRYOPORT, INC. operating lease, cost for the quarter ending 2026-06-30 was $1.81M, a 13.74% decline year-over-year.
- CRYOPORT, INC. operating lease, cost for the quarter ending 2026-03-31 was $2.00M, a 1.48% decline year-over-year.
- CRYOPORT, INC. operating lease, cost for the quarter ending 2025-12-31 was $2.03M, a 28.45% increase year-over-year.
- CRYOPORT, INC. operating lease, cost for the quarter ending 2025-09-30 was $2.14M, a 47.48% increase year-over-year.
- CRYOPORT, INC. operating lease, cost for fiscal 2025 was $8.29M, a 45.30% increase from fiscal 2024.
- CRYOPORT, INC. operating lease, cost for fiscal 2024 was $5.71M, a 11.66% increase from fiscal 2023.
- CRYOPORT, INC. operating lease, cost for fiscal 2023 was $5.11M, a 7.16% decline from fiscal 2022.
- CRYOPORT, INC. operating lease, cost for fiscal 2022 was $5.50M, a 20.83% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.81M 10-Q · filed 2026-08-06 | $5.83M derived: sum of 3 quarters · filed 2026-08-06 | $7.97M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.00M 10-Q · filed 2026-05-05 | $4.03M derived: sum of 2 quarters · filed 2026-05-05 | $6.17M derived: sum of 3 quarters · filed 2026-05-05 | $8.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.17M derived: sum of 2 quarters · filed 2026-03-05 | $6.26M derived: sum of 3 quarters · filed 2026-08-06 | $8.29M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.24M derived: sum of 2 quarters · filed 2026-08-06 | $6.26M 10-Q · filed 2025-11-06 | $7.84M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.13M 10-Q · filed 2026-08-06 | $5.70M derived: sum of 3 quarters · filed 2026-08-06 | $7.15M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.03M 10-Q · filed 2026-05-05 | $3.61M derived: sum of 2 quarters · filed 2026-05-05 | $5.06M derived: sum of 3 quarters · filed 2026-05-05 | $6.36M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.03M derived: sum of 2 quarters · filed 2026-03-05 | $4.33M derived: sum of 3 quarters · filed 2026-03-05 | $5.71M 10-K · filed 2026-03-05 | $8.32M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.76M derived: sum of 2 quarters · filed 2025-11-06 | $4.13M 10-Q · filed 2025-11-06 | $6.15M 10-Q · filed 2024-11-07 | $3.95M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2024-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.68M 10-Q · filed 2025-08-12 | $3.98M 10-Q · filed 2024-08-08 | $2.50M derived: sum of 3 quarters · filed 2026-03-05 | $4.34M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2024-03-31 | $1.37M 10-Q · filed 2025-05-08 | $2.05M 10-Q · filed 2024-05-08 | $1.19M derived: sum of 2 quarters · filed 2026-03-05 | $3.03M derived: sum of 3 quarters · filed 2026-03-05 | $4.70M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2023-12-31 | -$181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.66M derived: sum of 2 quarters · filed 2026-03-05 | $3.33M derived: sum of 3 quarters · filed 2026-03-05 | $5.11M 10-K · filed 2026-03-05 | $7.29M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.51M derived: sum of 2 quarters · filed 2024-11-07 | $5.29M 10-Q · filed 2024-11-07 | $6.86M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.45M 10-Q · filed 2024-08-08 | $5.02M derived: sum of 3 quarters · filed 2025-03-07 | $6.43M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $1.78M 10-Q · filed 2024-05-08 | $3.35M derived: sum of 2 quarters · filed 2025-03-07 | $4.76M derived: sum of 3 quarters · filed 2025-03-07 | $6.04M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.98M derived: sum of 2 quarters · filed 2025-03-07 | $4.26M derived: sum of 3 quarters · filed 2025-03-07 | $5.50M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.69M derived: sum of 2 quarters · filed 2023-11-09 | $3.94M 10-Q · filed 2023-11-09 | $5.33M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.53M 10-Q · filed 2023-08-09 | $3.92M derived: sum of 3 quarters · filed 2024-03-13 | $5.09M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | $1.24M 10-Q · filed 2023-05-04 | $2.64M derived: sum of 2 quarters · filed 2024-03-13 | $3.80M derived: sum of 3 quarters · filed 2024-03-13 | $4.88M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.56M derived: sum of 2 quarters · filed 2024-03-13 | $3.63M derived: sum of 3 quarters · filed 2024-03-13 | $4.56M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $2.24M derived: sum of 2 quarters · filed 2022-11-04 | $3.16M 10-Q · filed 2022-11-04 | $3.16K 10-Q · filed 2021-11-04 | $5.00M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.00M 10-Q · filed 2022-08-04 | $2.00K 10-Q · filed 2021-08-06 | $3.83M derived: sum of 3 quarters · filed 2023-02-28 | $3.83M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $922.00K 10-Q · filed 2022-05-05 | $922.00 10-Q · filed 2021-05-06 | $2.76M derived: sum of 2 quarters · filed 2023-02-28 | $2.76M derived: sum of 3 quarters · filed 2023-02-28 | $2.76M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.83M derived: sum of 2 quarters · filed 2023-02-28 | $1.83M derived: sum of 3 quarters · filed 2023-02-28 | $1.83M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $370.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $681.00 derived: sum of 2 quarters · filed 2021-11-04 | $971.00 10-Q · filed 2021-11-04 | $971.28K 10-Q · filed 2020-11-06 | $252.67K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $311.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $601.00 10-Q · filed 2021-08-06 | $601.02K 10-Q · filed 2020-08-10 | $252.30K derived: sum of 3 quarters · filed 2022-02-28 | $479.10K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $290.00 10-Q · filed 2021-05-06 | $290.11K 10-Q · filed 2020-05-08 | $251.99K derived: sum of 2 quarters · filed 2022-02-28 | $478.79K derived: sum of 3 quarters · filed 2022-02-28 | $634.19K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $251.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $478.50K derived: sum of 2 quarters · filed 2022-02-28 | $633.90K derived: sum of 3 quarters · filed 2022-02-28 | $758.00K 10-K · filed 2022-02-28 | $757.56K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $226.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $382.20K derived: sum of 2 quarters · filed 2019-11-12 | $506.30K 10-Q · filed 2019-11-12 | |||||
| 2019-06-30 | $155.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $279.50K 10-Q · filed 2019-08-09 | ||||||
| 2019-03-31 | $124.10K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |